In fact, together the April and May 2017 Medicare Part D formulary updates included a total of 49 new generic equivalents (manufacturer, drug, strength, and packaging combinations) representing 25 specific generic drugs.
The National Drug Code (NDC) uniquely identifies a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.
Some interesting additions to
the 2017 formularies include:
|
|
Number of |
Number of |
| GLYBURIDE 1.25 MG / METFORMIN HYDROCHLORIDE 250 MG ORAL TABLET [Glucovance] | 20 | 145 |
| LOPINAVIR-RITONAVIR 80-20MG/ML [Kaletra] | 56 | 326 |
| ABACAVIR-LAMIVUDINE 600-300 MG [Epzicom] | 57 | 331 |
| AMLODIPINE-OLMESARTAN 10-20 MG [Azor] | 31 | 193 |
| APREPITANT 125 MG CAPSULE [Emend] | 50 | 310 |
| CLINDAMYCIN PHOSPHATE-BENZOYL PEROXIDE 1.2-5% [Benzaclin] | 19 | 127 |
| CLINDAMYCIN-TRETINOIN
1.2%-0.025% [Veltin, Ziana] |
11 | 77 |
| DAPTOMYCIN 500 MG VIAL [Cubicin] | 53 | 316 |
| DROSP-EE-LEVOMEF 3-0.02-0.451 [Beyaz, Safyral] | 24 | 128 |
| ETHACRYNIC ACID 25 MG TABLET [Edecrin] | 13 | 109 |
| ETHYNODIOL-ETH ESTRA 1MG-50MCG [ZOVIA] | 49 | 284 |
| EZETIMIBE 10 MG TABLET [Zetia] | 28 | 221 |
| FENOFIBRATE 150 MG CAPSULE [LIPOFEN] | 7 | 105 |
| FLURANDRENOLIDE 0.05% LOTION [Cordran] | 7 | 72 |
| IRBESARTAN 150 MG TABLET [Avapro] | 57 | 330 |
| NILUTAMIDE 150 MG TABLET [Nilandron] | 57 | 327 |
| OLMESARTAN MEDOXOMIL 20 MG TAB [Benicar] | 37 | 218 |
| OLMSRTN-AMLDPN-HCTZ 20-5-12.5 [TRIBENZOR] | 35 | 184 |
| OSELTAMIVIR PHOS 30 MG CAPSULE [Tamiflu] | 57 | 310 |
| PARICALCITOL 1 MCG CAPSULE [Zemplar] | 57 | 317 |
| QUETIAPINE ER 150 MG TABLET [Seroquel] | 34 | 271 |
| RASAGILINE MESYLATE 0.5 MG TABLET [Azilect] | 50 | 311 |
| TELMISARTAN-HCTZ 40-12.5 MG TB [Micardis] | 39 | 249 |
| TOBRAMYCIN 10
MG/ML VIAL [Bethkis, Tobi, Tobi Podhaler, Tobramycin Sulfate] |
57 | 325 |
| VALGANCICLOVIR HCL 50 MG/ML [Valcyte] | 50 | 277 |
The following table details the 47 manufacturer / drug / strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the April 2017 updates. You can click on the NDC or Drug Name below to go to our on this site DrugFinder to see the details of how this drug is handled by all Medicare Part D Plans in Florida -- You can then change the state to your state for details in your service area.
| April 2017 Generic Medications Added to Medicare Part D | |||||||||||
| NDC | Generic Drug Name | Brand-Name Drug | |||||||||
| 66993048230 | ABACAVIR-LAMIVUDINE 600-300 MG | [Epzicom] | |||||||||
| 57664077383 | AMLODIPINE-OLMESARTAN 10-20 MG | [Azor] | |||||||||
| 57664077583 | AMLODIPINE-OLMESARTAN 10-40 MG | [Azor] | |||||||||
| 57664077283 | AMLODIPINE-OLMESARTAN 5-20 MG | [Azor] | |||||||||
| 57664077483 | AMLODIPINE-OLMESARTAN 5-40 MG | [Azor] | |||||||||
| 00781232368 | APREPITANT 125 MG CAPSULE | [Emend] | |||||||||
| 00781406336 | APREPITANT 125-80-80 MG PACK | [Emend] | |||||||||
| 00781232151 | APREPITANT 40 MG CAPSULE | [Emend] | |||||||||
| 00781232268 | APREPITANT 80 MG CAPSULE | [Emend] | |||||||||
| 00781716119 | CLINDAMYCIN PHOSPHATE-BENZOYL PEROXIDE 1.2-5% | [Benzaclin] | |||||||||
| 00472179060 | CLINDAMYCIN-TRETINOIN 1.2%-0.025% | [Veltin, Ziana] | |||||||||
| 00703012501 | DAPTOMYCIN 500 MG VIAL | [Cubicin] | |||||||||
| 00781407515 | DROSP-EE-LEVOMEF 3-0.02-0.451 | [Beyaz, Safyral] | |||||||||
| 68682001110 | ETHACRYNIC ACID 25 MG TABLET | [Edecrin] | |||||||||
| 00378730653 | ETHYNODIOL-ETH ESTRA 1MG-50MCG | [ZOVIA] | |||||||||
| 49884022809 | EZETIMIBE 10 MG TABLET | [Zetia] | |||||||||
| 62559046190 | FENOFIBRATE 150 MG CAPSULE | [LIPOFEN] | |||||||||
| 62559046090 | FENOFIBRATE 50 MG CAPSULE | [LIPOFEN] | |||||||||
| 51672529808 | FLURANDRENOLIDE 0.05% LOTION | [Cordran] | |||||||||
| 43547027803 | IRBESARTAN 150 MG TABLET | [Avapro] | |||||||||
| 62559017331 | NILUTAMIDE 150 MG TABLET | [Nilandron] | |||||||||
| 00378711277 | OLMESARTAN MEDOXOMIL 20 MG TAB | [Benicar] | |||||||||
| 00378712493 | OLMESARTAN MEDOXOMIL 40 MG TAB | [Benicar] | |||||||||
| 00378701293 | OLMESARTAN MEDOXOMIL 5 MG TAB | [Benicar] | |||||||||
| 49884078609 | OLMSRTN-AMLDPN-HCTZ 20-5-12.5 | [TRIBENZOR] | |||||||||
| 49884078909 | OLMSRTN-AMLDPN-HCTZ 40-10-12.5 | [TRIBENZOR] | |||||||||
| 49884079009 | OLMSRTN-AMLDPN-HCTZ 40-10-25MG | [TRIBENZOR] | |||||||||
| 49884078709 | OLMSRTN-AMLDPN-HCTZ 40-5-12.5 | [TRIBENZOR] | |||||||||
| 49884078809 | OLMSRTN-AMLDPN-HCTZ 40-5-25 MG | [TRIBENZOR] | |||||||||
| 47781046813 | OSELTAMIVIR PHOS 30 MG CAPSULE | [Tamiflu] | |||||||||
| 47781046913 | OSELTAMIVIR PHOS 45 MG CAPSULE | [Tamiflu] | |||||||||
| 47781047013 | OSELTAMIVIR PHOS 75 MG CAPSULE | [Tamiflu] | |||||||||
| 10888500102 | PARICALCITOL 1 MCG CAPSULE | [Zemplar] | |||||||||
| 10888500202 | PARICALCITOL 2 MCG CAPSULE | [Zemplar] | |||||||||
| 10888500302 | PARICALCITOL 4 MCG CAPSULE | [Zemplar] | |||||||||
| 49884080602 | QUETIAPINE ER 150 MG TABLET | [Seroquel] | |||||||||
| 49884080702 | QUETIAPINE ER 200 MG TABLET | [Seroquel] | |||||||||
| 49884080802 | QUETIAPINE ER 300 MG TABLET | [Seroquel] | |||||||||
| 16729009712 | QUETIAPINE ER 400 MG TABLET | [Seroquel] | |||||||||
| 49884080502 | QUETIAPINE ER 50 MG TABLET | [Seroquel] | |||||||||
| 47781013830 | RASAGILINE MESYLATE 0.5 MG TABLET | [Azilect] | |||||||||
| 47781013930 | RASAGILINE MESYLATE 1 MG TABLET | [Azilect] | |||||||||
| 13668015930 | TELMISARTAN-HCTZ 40-12.5 MG TB | [Micardis] | |||||||||
| 33342012907 | TELMISARTAN-HCTZ 80-12.5 MG TB | [Micardis] | |||||||||
| 13668016130 | TELMISARTAN-HCTZ 80-25 MG TAB | [Micardis] | |||||||||
| 63323030502 | TOBRAMYCIN 10 MG/ML VIAL | [Bethkis, Tobi, Tobi Podhaler, Tobramycin Sulfate] |
|||||||||
| 00591257920 | VALGANCICLOVIR HCL 50 MG/ML | [Valcyte] | |||||||||
What Could the Addition of New Generic Drugs Mean to You?
- You may be able to save money by switching
from the brand-name drug to its generic equivalent – with your prescriber’s
approval and a new prescription. Please note, you will need to look
carefully at coverage costs as we have found that many 2017 generics are being
offered on the same tier as their brand-name equivalent or the generics do not
have a significantly lower retail price. For example,
the brand-name Tamiflu
(45 mg) may have a retail cost of around $132.16 as a Tier 4 drug (35%
co-insurance) and the same plan may now cover the generic equivalent OSELTAMIVIR PHOS 45 MG also as a Tier 4 drug (35% co-insurance). You can click
here to see how your Medicare drug plan is covering these medication.
- Your brand-name drug may no longer be available if a generic is now available. From past experience, we may find that many Medicare Part D plans discontinue coverage of a brand-name drug in the months following the introduction of a generic equivalent. If you have received notice from your Medicare Part D plan that your brand-name medication will be dropped, you should speak with your prescriber to determine if you can take the generic equivalent or if you will need to ask your plan for a formulary exception to continue coverage for the brand-name drug. You can click for a chart showing the trends in formulary coverage for some of the most popular Medicare drugs and their generic equivalents.
You can review any Medicare plan formulary using the on this site FormularyBrowser at FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your service area using our on this site.